Nessa Carey
Profile
Nessa Carey is a professional who has worked as Director-Molecular Biology at Ligand UK Ltd., Senior Lecturer at Imperial College London, and Head-Biology at TopoTarget UK Ltd.
She holds a doctorate from The University of Edinburgh and an undergraduate degree from the University of Surrey.
Former positions of Nessa Carey
| Companies | Position | End |
|---|---|---|
| VERNALIS | Corporate Officer/Principal | - |
| Imperial College London | Corporate Officer/Principal | - |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Training of Nessa Carey
| The University of Edinburgh | Doctorate Degree |
| University of Surrey | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Retail Trade |
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Nessa Carey
